Comparative analysis of metabolic and structural changes in the skeletal muscles and myocardium of rats on the background of long-term administration of simvastatin

Author:

Belousova E. S.1ORCID,Mikashinovich Z. I.1ORCID,Vinogradova E. V.1ORCID,Loseva T. D.1ORCID

Affiliation:

1. Rostov State Medical University

Abstract

Objective: to conduct a comparative analysis of the dynamics of changes in the end products of glycolysis and the isoform composition of the giant protein - titin and nebulin in the skeletal and cardiac muscles of animals with HC during long-term administration of simvastatin. Materials and methods: the study was conducted on rats that were kept on a high-fat and high-carbohydrate  diet for three months. After GC confirmation, the animals were divided into groups: group 1 received only the experimental diet; group 2 received simvastatin in the form of an aqueous suspension for two months at the rate of 0.012 g/kg of animal weight once a day. The control group of animals was kept on the general diet of the vivarium. Results: The formation of HCh was accompanied  by the accumulation  of pyruvate and lactic acid both in the myocardium and in muscle tissue. The revealed metabolic changes reflect structural disorders and indicate the formation of hypoxia. Against the background of the introduction of simvastatin, both in the myocardium and in the skeletal muscles, a decrease in the level of pyruvate and lactic acid was noted and these indicators approached the values of the control group. Such changes reflect a tendency to restore the integration of intracellular metabolic processes. However, in the study of titin and nebulin proteins against the background of the use of simvastatin, both in the myocardium and in skeletal muscles, structural changes were noted: accumulation  of the proteolytic T-fragment, a decrease in the content of intact titin isoforms. Also, statin-induced structural abnormalities have been identified in earlier studies of rat muscle biopsies. Conclusion: The conducted comparative study clearly demonstrates that the myocardium, along with skeletal muscles, is the target organ of the toxic effect of statins. Based on this, the data obtained as a result of the study, it is important to take into account the pharmacotherapy with statins.

Publisher

Rostov State Medical University

Subject

General Medicine

Reference24 articles.

1. Гуревич В.С., Козиолова Н.А., Ежов М.В., Сергиенко И.В., Алиева А.С., Вавилова Т.В., и др. Нерешенные проблемы дислипидемии и резидуального сердечно-сосудистого риска. Атеросклероз и дислипидемии. 2022;1(46):31–39. doi: 10.34687/2219-8202.JAD.2022.01.0003

2. Дзугкоев С.Г., Гармаш О.Ю., Дзугкоева Ф.С. Патогенетическое обоснование примененеия ингибитора 3-гидрокси-3-метилглутарил-коэнзим А редуктазы и антиоксиданта коэнзима Q10 в лечении и профилактике сердечно-сосудистой патологии. Кардиоваскулярная терапия и профилактика. 2021;20 (6):127-133. doi:10.15829/1728-8800-2021-2793.

3. Colhoun H.M., Betteridge D.J., Durrington P.N., Hitman G.A., Neil H.A., Livingstone S.J., et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomized placebo-controlled trial. Lancet. 2004;364 (9435):685-96. doi: 10.1016/S0140-6736(04)16895-5

4. Зыков М.B. Проблема безопасности липидснижающей терапии. Кардиология. 2019;59(5S):13-26. doi: 10.18087/cardio.2505

5. Okuyama H., Langsjoen P.H., Hamazaki T., Ogushi Y., Hama R., Kobayashi T., et al. Statins stimulate atherosclerosis and heart failure: pharmacological mechanisms. Expert Rev Clin Pharmacol. 2015;8(2):189-199. doi: 10.1586/17512433.2015.1011125.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3